In our study, we observed no correlation between TRAIL and CCL20, supporting the conclusion, that CCL20 is an inflammatory marker specific for schizophrenia, while TRAIL is a transdiagnostic marker for SZ and MDD, with possibly different underlying pathways or non-linear relationships. This evidence concerns the gene TNFSF10 and major depressive disorder.